Talukder, MesbahIslam, S.M. Zahidul2024-06-062024-06-06©202220222022-11ID: 18346042http://hdl.handle.net/10361/23210Cataloged from the PDF version of thesis.Includes bibliographical references (pages 39-41).This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.Background: One of the primary causes of male pattern baldness is thought to be the conversion of testosterone to dihydrotestosterone. Dutasteride, a dual 5-alpha-reductase inhibitor, can prevent this conversion from proceeding in the body. Objectives: To summarize treatment patterns, baseline characteristics, and the effectiveness and long-term safety and mesotherapy of dutasteride. Methods: Systemic or structured search. Efficacy: Dutasteride demonstrated considerably greater efficacy than placebo (Eun et al., 2010). Dutasteride was more successful than finasteride for treating AGA in male patients. Erectile dysfunction (P = 0.07), safety, changed libido (P = 0.54), and ejaculatory difficulties (P = 0.58) did not differ significantly between dutasteride and finasteride (Zhou et al., 2019). Conclusions: This study unequivocally established that dutasteride increased hair growth while being generally well tolerated in general for the treatment of MPHL.52 pagesenBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.Androgenetic AlopeciaMale pattern hair lossMesotherapyFinasterideAlopecia areataHair--DiseasesThesis